Risk of worsening renal function with nesiritide in HF patients

被引:0
|
作者
机构
关键词
Placebo; Heart Failure; Creatinine; Renal Function; Serum Creatinine;
D O I
10.2165/00128415-200510460-00018
中图分类号
学科分类号
摘要
引用
收藏
页码:5 / 5
相关论文
共 50 条
  • [2] Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure
    Sackner-Bernstein, JD
    Skopicki, HA
    Aaronson, KD
    CIRCULATION, 2005, 111 (12) : 1487 - 1491
  • [3] Risk of worsening renal function with nesiritide following cardiac surgery
    Kristeller, Judith Lyn
    Papps, Haley
    Stahl, Russell F.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2006, 63 (23) : 2351 - 2353
  • [4] Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine
    Wang, DJ
    Dowling, TC
    Meadows, D
    Ayala, T
    Marshall, J
    Minshall, S
    Greenberg, N
    Thattassery, E
    Fisher, ML
    Rao, K
    Gottlieb, SS
    CIRCULATION, 2004, 110 (12) : 1620 - 1625
  • [5] Lack of association between worsening renal function and mortality in heart failure patients treated with nesiritide
    Miller, Wayne L.
    Kurien, Shaun
    Warfield, Karen T.
    Wood, Christina M.
    Jaffe, Allan S.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 126 (02) : 234 - 239
  • [6] Nesiritide and worsening of renal function - The emperor's new clothes?
    Teerlink, JR
    Massie, BM
    CIRCULATION, 2005, 111 (12) : 1459 - 1461
  • [7] Risk-factors of worsening renal function in hospitalized elderly patients
    Burkhardt, H
    Bruckner, D
    Gladisch, R
    JOURNAL OF NEPHROLOGY, 2005, 18 (02) : 166 - 173
  • [8] Impact of Nesiritide on Renal Function and Mortality in Patients Suffering from Heart Failure
    Ioannis D. Dontas
    Theodoros Xanthos
    Ismene Dontas
    Pavlos Lelovas
    Lila Papadimitriou
    Cardiovascular Drugs and Therapy, 2009, 23 : 221 - 233
  • [9] Impact of Nesiritide on Renal Function and Mortality in Patients Suffering from Heart Failure
    Dontas, Ioannis D.
    Xanthos, Theodoros
    Dontas, Ismene
    Lelovas, Pavlos
    Papadimitriou, Lila
    CARDIOVASCULAR DRUGS AND THERAPY, 2009, 23 (03) : 221 - 233